Suggesting 7,8-dihydroxyflavone as a promising nutraceutical against CNS disorders
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Neurochemistry International
- Vol. 148, 105068
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- 7,8-dihydroxyflavone, a small-molecule tropomyosin-related kinase B (TrkB) agonist, attenuates cerebral ischemia and reperfusion injury in ratsJournal of Molecular Histology, 2013
- Conditional ablation of brain-derived neurotrophic factor-TrkB signaling impairs striatal neuron developmentProceedings of the National Academy of Sciences, 2012
- 7,8-dihydroxyflavone exhibits therapeutic efficacy in a mouse model of Rett syndromeJournal of Applied Physiology, 2012
- 7,8-Dihydroxyflavone, a Small-Molecule TrkB Agonist, Reverses Memory Deficits and BACE1 Elevation in a Mouse Model of Alzheimer's DiseaseNeuropsychopharmacology, 2011
- Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degenerationExperimental Neurology, 2011
- A Synthetic 7,8-Dihydroxyflavone Derivative Promotes Neurogenesis and Exhibits Potent Antidepressant EffectJournal of Medicinal Chemistry, 2010
- Lead Exposure during Synaptogenesis Alters Vesicular Proteins and Impairs Vesicular Release: Potential Role of NMDA Receptor–Dependent BDNF SignalingToxicological Sciences, 2010
- A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavoneProceedings of the National Academy of Sciences, 2010
- Th1, Th17, and Th9 Effector Cells Induce Experimental Autoimmune Encephalomyelitis with Different Pathological PhenotypesThe Journal of Immunology, 2009
- Do thin spines learn to be mushroom spines that remember?Current Opinion in Neurobiology, 2007